Summary
- Current Price
- As of today, RLMD price is $5.37, down -1.29% on
- Current Price All-Time High
- RLMD price is currently -93.29% below its historical high of $80.00 set on
- Market Cap
- RLMD current market cap is $564M, up +2721.54% over the past 365 days
- Revenue
- RLMD current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for RLMD has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Relmada Therapeutics, Inc. |
| Ticker | NASDAQ: RLMD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | relmada.com |
| Employees | 17 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $5.37 | |
| Price, 1D Change | -1.29% | |
| $564M | ||
| - | ||
| - | ||
| 1.43 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.45 | ||
| EPS, 1Y Change | +45.18% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.45 | ||
| EPS Estimate | -$0.41 | N/A |
| EPS Est. Change | +71.79% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $5.37 | |
| Price Target | $12.00 | - |
| Price Tgt. Change | +123.46% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.72 | -$2.65 | -54.16% | |
| -$0.83 | -$1.45 | -75.12% | |
| -$0.41 | N/A | +71.79% | |
| -$0.41 | N/A | +71.79% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $5.37 | |
| $5.28 | ||
| $6.13 | ||
| $5.20 | ||
| $5.96 | ||
| -$0.25 | ||
| 1.43 | ||
| $0.36 | ||
| 41.75 | ||
| 29.95% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.45 | ||
| $0.00 | ||
| - | ||
| -$59.10M | ||
| - | ||
| -$57.39M | ||
| - | ||
| -$59.10M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 14.62 | ||
| 14.62 | ||
| - | ||
| - | ||
| 33.80 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.58 | ||
| -5.47 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $86.51M | ||
| $93.01M | ||
| $94.00M | ||
| $93.98M | ||
| $7.49M | ||
| $6.43M | ||
| $0.00 | ||
| $0.00 | ||
| $1.57M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $57.39M | ||
| $59.10M | ||
| $0.00 | ||
| $32.22M | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$45.79M | ||
| -$48.14M | ||
| $93.56M | ||
| $0.00 | ||
| -$45.79M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | ||
| Piper Sandler | ||
| Mizuho | → | |
| LUCID CAPITAL MARKETS | ||
| Leerink Partners | → | |
| Jefferies | ||
| Mizuho | → | |
| Mizuho | → | |
| Leerink Partners | → | |
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
No data
Screeners with RLMD
FAQ
- What is the ticker symbol for Relmada Therapeutics, Inc.?
- The ticker symbol for Relmada Therapeutics, Inc. is NASDAQ:RLMD
- Does Relmada Therapeutics, Inc. pay dividends?
- No, Relmada Therapeutics, Inc. does not pay dividends
- What sector is Relmada Therapeutics, Inc. in?
- Relmada Therapeutics, Inc. is in the Healthcare sector
- What industry is Relmada Therapeutics, Inc. in?
- Relmada Therapeutics, Inc. is in the Biotechnology industry
- What country is Relmada Therapeutics, Inc. based in?
- Relmada Therapeutics, Inc. is headquartered in United States
- When did Relmada Therapeutics, Inc. go public?
- Relmada Therapeutics, Inc. initial public offering (IPO) was on June 20, 2014
- Is Relmada Therapeutics, Inc. in the S&P 500?
- No, Relmada Therapeutics, Inc. is not included in the S&P 500 index
- Is Relmada Therapeutics, Inc. in the NASDAQ 100?
- No, Relmada Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Relmada Therapeutics, Inc. in the Dow Jones?
- No, Relmada Therapeutics, Inc. is not included in the Dow Jones index
- When was Relmada Therapeutics, Inc. last earnings report?
- Relmada Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Relmada Therapeutics, Inc. report earnings?
- The date for Relmada Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- RLMD Official Website www.relmada.com
- RLMD Profile on Yahoo Finance finance.yahoo.com/quote/RLMD
- RLMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rlmd